Chewing and swallowing performance in people with scleroderma

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center observational project at Hacettepe University that looks at chewing and swallowing function in both children and adults with scleroderma. Participants complete standardized questionnaires covering physical, psychological, and social aspects of their condition and specific items about chewing and swallowing. People with advanced organ failure, neurological disease, malignancy, or unwillingness to participate are excluded. The study also aims to identify which clinical scales work best for future research and clinical monitoring.

Why it matters

Who can join: the full rules

For a child diagnosed with scleroderma:

Inclusion Criteria:

* Cases diagnosed with scleroderma,
* Cases aged 7-18 years will be included.

Exclusion Criteria:

* Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
* Cases that are not willing to participate in the study will be excluded.
* Having participated in a regular exercise program for the past 3 months
* Individuals who are not willing to participate in the study

For adults diagnosed with scleroderma:

Inclusion Criteria:

* Individuals diagnosed with scleroderma,
* Individuals over the age of 18 will be included.

Exclusion Criteria:

* Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
* Individuals who are not willing to participate in the study will be excluded.
* Having participated in a regular exercise program for the past 3 months
* Individuals who are not willing to participate in the study

Where it's running

• Hacettepe University
  Çankaya, Ankara, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Orkun Tüfekçi, PT, PhD(c)
• Email: orkuntf@gmail.com
• Phone: 5319502648

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Biopsychosocial (BETY) exercise program for children and adults with scleroderma

  This project will test whether BETY, a biopsychosocial exercise program, helps children and adults with scleroderma improve physical function and psychosocial well-being.

  Recruiting Hacettepe University · Ankara, Altındağ · NCT07292961

• Physical performance and daily function in people with scleroderma

  This project will test which questionnaires and simple physical tests best measure physical performance and daily functioning in children and adults with scleroderma.

  Recruiting Hacettepe University · Çankaya, Ankara · NCT07183072

• First-in-human test of PRO-203 in healthy adults and people with systemic sclerosis

  Researchers will test a single subcutaneous dose of PRO-203 in healthy adults and in people with systemic sclerosis to see if it is safe and how the body handles it.

  Recruiting at 12 sites Phase 1/2 Prolium Bioscience, Inc · Melbourne, Victoria and 12 other locations · NCT07641634

• Turkish PASTUL questionnaire for measuring upper‑limb skin thickness in systemic sclerosis

  This project will test a Turkish version of the PASTUL questionnaire to see if people with systemic sclerosis can use it to measure their upper‑limb skin thickness.

  Recruiting Hacettepe University · Çankaya, Ankara · NCT07182968

• AlloNK® therapy combined with rituximab for treating certain autoimmune diseases

  This study is testing if a new treatment called AlloNK® combined with rituximab can help people with tough-to-treat autoimmune diseases feel better.

  Recruiting at 52 sites Phase 2 Artiva Biotherapeutics, Inc. · Tuscaloosa, Alabama and 51 other locations · NCT06991114

• Progressive Muscle Relaxation for Fatigue and Breathing in Systemic Sclerosis

  Aims to see if progressive muscle relaxation can help reduce fatigue and breathing difficulties and improve lung function in adults with systemic sclerosis.

  Recruiting University of Gaziantep · Gaziantep, Şehitkamil · NCT07842133

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.